Similar articles

• [Do other proton pump blockers have advantages over Antra (omeprazole)?].

  Creutzfeldt W. Creutzfeldt W. Internist (Berl). 1996 Sep;37(9):936-7. Internist (Berl). 1996. PMID: 8964689 German. No abstract available.
• Proton-pump inhibitors: three of a kind?

  Bateman DN. Bateman DN. Lancet. 1997 Jun 7;349(9066):1637-8. doi: 10.1016/s0140-6736(05)62629-3. Lancet. 1997. PMID: 9186377 No abstract available.
• [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].

  Wilson BV, Knudsen T. Wilson BV, et al. Ugeskr Laeger. 1996 Mar 18;158(12):1695-7. Ugeskr Laeger. 1996. PMID: 8644421 Danish. No abstract available.
• Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.

  Welage LS, Berardi RR. Welage LS, et al. J Am Pharm Assoc (Wash). 2000 Jan-Feb;40(1):52-62; quiz 121-3. doi: 10.1016/s1086-5802(16)31036-1. J Am Pharm Assoc (Wash). 2000. PMID: 10665250 Review.
• [Are proton pump inhibitors safe?].

  Creutzfeldt W. Creutzfeldt W. Internist (Berl). 1994 Dec;35(12):1137-46. Internist (Berl). 1994. PMID: 7883517 Review. German. No abstract available.